Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of plasmapheresis on tetanus antibody titers in regular plasma donors
2014-001995-71Phase 4Terminated
- Sponsor
- Plazmaferezis Állomás
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Tetanus Vaccine (Adsorbed) in Tetanus, sponsored by Plazmaferezis Állomás. Primary endpoint: Change in tetanus antibody titer after regular plasma donation. Started May 2014; status: terminated.
02
Drugs
Tetanus Vaccine (Adsorbed)
03
Conditions
Tetanus
Beyond the preview
Go deeper on 2014-001995-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001995-71.